ETFs GSK plc NYSE

GSK

US37733W2044

Pharmaceuticals

Market Closed - NYSE 16:00:02 2026-10-02 EDT			5-day change	1st Jan Change
47.03 ^USD	-0.32%		-4.49%	-4.10%

10-02	Major drugmakers turn to China for licensing deals	RE
10-01	GSK plc : JP Morgan reiterates its Sell rating	ZD

ETFs positioned on GSK plc

Name	YTD change	Weight	AuM
VANECK PHARMACEUTICAL ETF - USD	+4.74%	4.9%	968 M€
SOUND EQUITY INCOME ETF - USD	+11.10%	4.54%	29 M€
KEATING ACTIVE ETF - USD	+6.84%	3.57%	123 M€
HORIZON KINETICS MEDICAL ETF - USD	+4.39%	3.16%	17 M€
ALTRIUS GLOBAL DIVIDEND ETF - USD	+10.31%	2.38%	21 M€
AAM BRENTVIEW DIVIDEND GROWTH ETF - USD	+7.19%	1.7%	7 M€
AVANTIS INTERNATIONAL LARGE CAP VALUE ETF - USD	+11.57%	1.13%	2,052 M€
SGI ENHANCED GLOBAL INCOME ETF - USD	+13.01%	0.94%	105 M€
FIDELITY FUNDAMENTAL LARGE CAP VALUE ETF - USD	+13.57%	0.82%	19 M€
FIDELITY ENHANCED INTERNATIONAL ETF - USD	+9.35%	0.64%	11,331 M€
AVANTIS RESPONSIBLE INTERNATIONAL EQUITY ETF - USD	+7.12%	0.57%	361 M€
SP FUNDS S&P WORLD (EX-US) ETF - USD	+25.49%	0.51%	210 M€
ACTIVEPASSIVE INTERNATIONAL EQUITY ETF - USD	+8.67%	0.47%	1,166 M€
AVANTIS INTERNATIONAL EQUITY ETF - USD	+9.73%	0.45%	18,816 M€
FIRST TRUST VALUE LINE DIVIDEND ETF - USD	+2.17%	0.43%	8,285 M€
DIMENSIONAL INTERNATIONAL HIGH PROFITABILITY ETF - USD	+7.22%	0.15%	6,576 M€
LEUTHOLD CORE ETF - USD	+5.60%	0.08%	68 M€
CAMBRIA US EW ETF - USD	+9.77%	0%	194 M€

GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).

Employees

66,841

Sector

Pharmaceuticals

Calendar

10-27 Earnings release - Q3 2026

More about the company